These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38528554)

  • 1. Synergistic dual cell therapy for atherosclerosis regression: ROS-responsive Bio-liposomes co-loaded with Geniposide and Emodin.
    Li Z; Zhu H; Liu H; Liu D; Liu J; Zhang Y; Qin Z; Xu Y; Peng Y; Ruan L; Li J; He Y; Liu B; Long Y
    J Nanobiotechnology; 2024 Mar; 22(1):129. PubMed ID: 38528554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artemisinin and Procyanidins loaded multifunctional nanocomplexes alleviate atherosclerosis via simultaneously modulating lipid influx and cholesterol efflux.
    Zhou H; You P; Liu H; Fan J; Tong C; Yang A; Jiang Y; Liu B
    J Control Release; 2022 Jan; 341():828-843. PubMed ID: 34942304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrin-mediated conjugation of macrophage and liposomes for treatment of atherosclerosis.
    Gao C; Liu C; Chen Q; Wang Y; Kwong CHT; Wang Q; Xie B; Lee SMY; Wang R
    J Control Release; 2022 Sep; 349():2-15. PubMed ID: 35779655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
    Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
    Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aortic plaque-targeted andrographolide delivery with oxidation-sensitive micelle effectively treats atherosclerosis via simultaneous ROS capture and anti-inflammation.
    Wu T; Chen X; Wang Y; Xiao H; Peng Y; Lin L; Xia W; Long M; Tao J; Shuai X
    Nanomedicine; 2018 Oct; 14(7):2215-2226. PubMed ID: 29964220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorin e6 (Ce6)-loaded plaque-specific liposome with enhanced photodynamic therapy effect for atherosclerosis treatment.
    Zou L; Zhang Y; Cheraga N; Abodunrin OD; Qu KY; Qiao L; Ma YQ; Chen LJ; Huang NP
    Talanta; 2023 Dec; 265():124772. PubMed ID: 37327664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foam Cell Targeted Liposomes Co-Encapsulating Superoxide Dismutase and Catalase to Attenuate Atherosclerosis by Inhibiting Oxidative Stress.
    Zhang S; Liu D; Zhang J; Liu S; Sun R; Huo R; Cui C
    Discov Med; 2024 Feb; 36(181):343-354. PubMed ID: 38409839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate-Modified Liposomes Loaded with Telmisartan Enhance Anti-Atherosclerotic Potency for Advanced Atherosclerosis in ApoE
    Fang D; Jin Q; Jin Z; Wang F; Huang L; Yang Y; He Z; Liu Y; Jiang C; Wu J; Song X
    J Biomed Nanotechnol; 2019 Jan; 15(1):42-61. PubMed ID: 30480514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin.
    Cheraga N; Ye Z; Xu MJ; Zou L; Sun NC; Hang Y; Shan CJ; Yang ZZ; Chen LJ; Huang NP
    Nanoscale; 2022 Jun; 14(24):8709-8726. PubMed ID: 35673987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geniposide alleviates atherosclerosis by regulating macrophage polarization via the FOS/MAPK signaling pathway.
    Jin Z; Li J; Pi J; Chu Q; Wei W; Du Z; Qing L; Zhao X; Wu W
    Biomed Pharmacother; 2020 May; 125():110015. PubMed ID: 32187958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect.
    Sha X; Dai Y; Chong L; Wei M; Xing M; Zhang C; Li J
    J Nanobiotechnology; 2022 Dec; 20(1):506. PubMed ID: 36456996
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Fang S; Sun S; Cai H; Zou X; Wang S; Hao X; Wan X; Tian J; Li Z; He Z; Huang W; Liang C; Zhang Z; Yang L; Tian J; Yu B; Sun B
    Theranostics; 2021; 11(19):9358-9375. PubMed ID: 34646375
    [No Abstract]   [Full Text] [Related]  

  • 13. Salvianolic acid B inhibits atherosclerosis and TNF-α-induced inflammation by regulating NF-κB/NLRP3 signaling pathway.
    Zhao Y; Shao C; Zhou H; Yu L; Bao Y; Mao Q; Yang J; Wan H
    Phytomedicine; 2023 Oct; 119():155002. PubMed ID: 37572566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supramolecular copolymer modified statin-loaded discoidal rHDLs for atherosclerotic anti-inflammatory therapy by cholesterol efflux and M2 macrophage polarization.
    Zhang Q; He J; Xu F; Huang X; Wang Y; Zhang W; Liu J
    Biomater Sci; 2021 Sep; 9(18):6153-6168. PubMed ID: 34346410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shear stress and ROS-responsive biomimetic micelles for atherosclerosis via ROS consumption.
    Shen M; Li H; Yao S; Wu X; Liu S; Yang Q; Zhang Y; Du J; Qi S; Li Y
    Mater Sci Eng C Mater Biol Appl; 2021 Jul; 126():112164. PubMed ID: 34082967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines.
    Gao C; Huang Q; Liu C; Kwong CHT; Yue L; Wan JB; Lee SMY; Wang R
    Nat Commun; 2020 May; 11(1):2622. PubMed ID: 32457361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil membrane biomimetic delivery system (Ptdser-NM-Lipo/Fer-1) designed for targeting atherosclerosis therapy.
    Li W; Liu C; Wang S; Liu N
    IET Nanobiotechnol; 2023 Jun; 17(4):387-395. PubMed ID: 37183611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic-Coated Nanoplatform with Lipid-Specific Imaging and ROS Responsiveness for Atherosclerosis-Targeted Theranostics.
    Ma B; Xu H; Wang Y; Yang L; Zhuang W; Li G; Wang Y
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35410-35421. PubMed ID: 34286950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-sponge-like liposomes remove cholesterol crystals for antiatherosclerosis.
    Gong F; Wang Z; Mo R; Wang Y; Su J; Li X; Omonova CTQ; Khamis AM; Zhang Q; Dong M; Su Z
    J Control Release; 2022 Sep; 349():940-953. PubMed ID: 35870569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network pharmacology and in vivo evidence of the pharmacological mechanism of geniposide in the treatment of atherosclerosis.
    Ma G; Dong Q; Li F; Jin Z; Pi J; Wu W; Li J
    BMC Complement Med Ther; 2024 Jan; 24(1):53. PubMed ID: 38267978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.